A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Thermo Fisher to Purchase Clario to Enhance Clinical Insights and Accelerate Innovation - The Healthcare Technology Report.
Thermo Fisher to Purchase Clario to Enhance Clinical Insights and Accelerate Innovation The Healthcare Technology Report.
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights - MedTech Intelligence
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights MedTech Intelligence
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal - Fierce Biotech
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal Fierce Biotech
Thermo Fisher to buy Clario for $8.8bn - Clinical Trials Arena
Thermo Fisher to buy Clario for $8.8bn Clinical Trials Arena
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion Reuters
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B MedTech Dive
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific - Latham & Watkins LLP
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific Latham & Watkins LLP
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - Business Wire
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights Business Wire
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - The Wall Street Journal
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion The Wall Street Journal
Thermo Fisher nears $10 billion takeover of Clario, FT reports - Reuters
Thermo Fisher nears $10 billion takeover of Clario, FT reports Reuters
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page